TITLE

THE EFFECT OF AMBUTONIUM BROMIDE, A NEW ANTICHOLINERGIC AGENT IN ULCER THERAPY

AUTHOR(S)
Schwartz, I. Richard; Lehman, Ernest; Seibel, Jack M.
PUB. DATE
June 1960
SOURCE
American Journal of Gastroenterology;Jun1960, Vol. 33 Issue 6, p704
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Complete or partial remission of symptoms associated with peptic ulcer or other "irritable" gastrointestinal disease was obtained in 162 (91 per cent) of 179 patients by the use of ambutonium bromide, aluminum hydroxide gel with magnesium hydroxide, and butabarbital, administered separately or in combination, and either in solution or in tablet form.
ACCESSION #
16457326

 

Related Articles

  • CLINICAL EXPERIENCE WITH A NEW LONG-ACTING ANTACID-ANTICHOLINERGIC PREPARATION. King, Joseph C. // American Journal of Gastroenterology;Oct1959, Vol. 32 Issue 4, p509 

    A new preparation, BepHan Spacetabs, has been evaluated in 78 patients to determine its usefulness in the treatment of a variety of gastrointestinal disorders. The results obtained in this series of cases indicates that this combination of an anticholinergic and two antacids was extremely...

  • Formulation and Evaluation of Mouth Dissolving Tablets of Ranitidine HCl. Sharma, Sachin; Kumar, Jitendra; Arya, Arun; Chandra, Amrish; Jaiswal, Pankaj // International Journal of PharmTech Research;Apr2010, Vol. 2 Issue 2, p1574 

    Ranitidine HCl is an H2 anhistaminic drug mainly used for treatment of peptic ulcers and is absorbed 50% orally. The drug undergoes hepatic metabolism, so the attempt has been made to administer it as mouth dissolving tablet to incresase its oral bioavailability. The tablets were prepared by...

  • THE TREATMENT OF GASTROINTESTINAL DISTURBANCES WITH MONODRAL® WITH AND WITHOUT MEPHOBARBITAL (MEBARAL®). Riese, J. A. // American Journal of Gastroenterology;Mar1959, Vol. 31 Issue 3, p313 

    1. Sixty-eight patients with peptic ulcer were treated with Monodral or Monodral with Mebaral. Ten patients with various other gastrointestinal disorders were also included in the study. 2. Results in the peptic ulcer group were considered excellent in 86.7 percent and satisfactory in 10.2...

  • Development of Tablet Formulations of Enteric Coated Esomeprazole with Acryl EZE. Kumar, Putta Rajesh; Shyale, Somashekar; Gouda, M. Mallikarjuna; Kumar, S. M. Shanta // Der Pharmacia Sinica;2011, Vol. 2 Issue 3, p31 

    Esomeprazole magnesium trihydrate tablets were formulated by directly compression and enteric coated with Acryl EZE. The rheological characteristics of powder beds were freely flowable and easily compressible. The Compressional parameters after enteric coating were found to be uniform and...

  • In vitro and In vivo Evaluations of a Tableted Antacid and Sucralfate, a New Antiulcer Agent. McGraw, Benjamin F.; Hesterlee, Edward J.; Lanza, Frank L.; Tesler, Max A. // American Journal of Gastroenterology;Nov1981, Vol. 76 Issue 5, p412 

    Sucralfate is a nonsystemic drug used in the therapy of peptic ulcer disease. It is an aluminum salt of a sulfated disaccharide which adheres to ulcerated sites and forms a cytoprotective barrier to acid peptic digestion. The purposes of this study were to determine whether sucralfate had...

  • STUDYING THE RELEASE RATIO OF SOME PPI'S IN DIFFERENT B10RELEVANT DISSOLUTION MEDIA. Housheh, S.; G.Bashour; Chehna, M. F. // International Journal of Pharmacy & Pharmaceutical Sciences;Apr2011, Vol. 3 Issue 2, p174 

    Lansoprazole, Omeprazole, and Esomeprazole are Benzimidazole derivatives; they belong to proton pump inhibitors group (PPIs). PPIs are used for treatment of peptic ulcer, GERD, and other gastrointestinal disorders. Dissolution test in Compendial and different biorelevant media had been applied...

  • Comparison of Clinical Features and Patient Background in Functional Dyspepsia and Peptic Ulcer. Hiroko Nakao; Hideyuki Konishi; Shoji Mitsufuji; Junko Yamauchi; Takeshi Yasu; Junko Taniguchi; Naoki Wakabayashi; Keisho Kataoka; Takeshi Okanoue // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2152 

    Abstract  To elucidate the clinical features of functional dyspepsia (FD), patients with FD were compared with patients with peptic ulcer. Fifty-eight FD and fifty-nine peptic ulcer patients were compared with respect to clinical features and patient background. In the FD group,...

  • Indigestion: When is it functional? Talley, Nicholas J; Nghi Phung; Kalantar, Jamshid S // BMJ: British Medical Journal (International Edition);12/1/2001, Vol. 323 Issue 7324, p1294 

    Discusses the diagnosis and treatment of dyspepsia. Various symptoms of the condition, including heartburn, abdominal pain, and acid regurgitation; Causes of dyspepsia, including gastro-esophageal reflux disease, peptic ulcers, gastric cancer, and gall stones; Pathogenesis, identification and...

  • Health Impact of Peptic Ulcer in the United States. Sonnenberg, Amnon; Everhart, James E. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p614 

    Objectives: To assess the general outcome and impact of current and previous peptic ulcer disease on health status in the United States. Methods: During the National Health Interview Survey of 1989, a special questionnaire on digestive diseases was administered to 41,457 randomly selected...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics